ConductScience.org, home

Paper42004157

Real-World Treatment Patterns in Patients with Atopic Dermatitis Initiating Ruxolitinib Cream: A 12-Month Follow-Up Analysis of a US Payer Claims Database.

Liu J and 6 others. Clinicoecon Outcomes Res, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Real-World Treatment Patterns in Patients with Atopic Dermatitis Initiating Ruxolitinib Cream: A 12-Month Follow-Up Analysis of a US Payer Claims Database. Papers, record 42004157. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42004157

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Real-World Treatment Patterns in Patients with Atopic Dermatitis Initiating Ruxolitinib Cream: A 12-Month Follow-Up Analysis of a US Payer Claims Database.
PubMed
Journal
Clinicoecon Outcomes Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu JJinan
2Desai KKarishma
3Chen HPHung-Yuan P
4Teng CCChia-Chen
5Sturm DDanielhttps://orcid.org/0009-0001-4413-8429
6Stockbower GEGrace E
7Willey VJVincent J

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133421555Atopic dermatitis in the pediatric population: A cross-sectional, international epidemiologic study.Ann Allergy Asthma Immunol2021https://conductscience.org/library/papers/33421555PubMed
237943240Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.J Am Acad Dermatol2024https://conductscience.org/library/papers/37943240PubMed
323452057Characterization of different courses of atopic dermatitis in adolescent and adult patients.Allergy2013https://conductscience.org/library/papers/23452057PubMed
439931253Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database.Clinicoecon Outcomes Res2025https://conductscience.org/library/papers/39931253PubMed
536641009Guidelines of care for the management of atopic dermatitis in adults with topical therapies.J Am Acad Dermatol2023https://conductscience.org/library/papers/36641009PubMed
637830436
Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxolitinib cream monotherapy.
J Dermatol2023https://conductscience.org/library/papers/37830436PubMed
738297490
Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies.
J Dermatolog Treat2024https://conductscience.org/library/papers/38297490PubMed
836066323Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis.J Eur Acad Dermatol Venereol2023https://conductscience.org/library/papers/36066323PubMed
938243107Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year.Am J Clin Dermatol2024https://conductscience.org/library/papers/38243107PubMed
1036264430Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies.Am J Clin Dermatol2023https://conductscience.org/library/papers/36264430PubMed
1130389491Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population.J Invest Dermatol2019https://conductscience.org/library/papers/30389491PubMed
1236095314Development and Validation of the Summary Elixhauser Comorbidity Score for Use With ICD-10-CM-Coded Data Among Older Adults.Ann Intern Med2022https://conductscience.org/library/papers/36095314PubMed
1336574595Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies.J Am Acad Dermatol2023https://conductscience.org/library/papers/36574595PubMed
1439760983A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2-11 Years with Moderate to Severe Atopic Dermatitis.Am J Clin Dermatol2025https://conductscience.org/library/papers/39760983PubMed
1533957195Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies.J Am Acad Dermatol2021https://conductscience.org/library/papers/33957195PubMed
1639707983Adverse event of ruxolitinib cream: a real-world analysis based on FDA Adverse Event Reporting System from 2021 to 2024.Expert Opin Drug Saf2026https://conductscience.org/library/papers/39707983PubMed
1736197589Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review.Dermatol Ther (Heidelb)2022https://conductscience.org/library/papers/36197589PubMed
1830417330Atopic dermatitis: the relationship to temperature and seasonality in the United States.Int J Dermatol2019https://conductscience.org/library/papers/30417330PubMed
1939375281Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication History.Dermatol Ther (Heidelb)2024https://conductscience.org/library/papers/39375281PubMed
2030025911Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study.Ann Allergy Asthma Immunol2018https://conductscience.org/library/papers/30025911PubMed

See all 34 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42554948Real-World Effect of Ruxolitinib Cream: Decreased Use of Additional Topical Therapies and Limited Escalation to Systemic Treatments.Adv Ther2026https://conductscience.org/library/papers/42554948

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42004157

GET https://conductscience.org/api/papers/v1/42004157/references?page=2